Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-21485

Xla Wt + myod1 MO, Maguire RJ et al. (2012)

Experiment + Assay: Xla Wt + myod1 MO + NF21 (immunohistochemistry)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection myod1 MO1 myod1.S
myod1.L
 NF stage 2 (2-cell) blastomere
morpholino injection myod1 MO2 myod1.L
myod1.S
 NF stage 2 (2-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
immunohistochemistry NF stage 21  
Anatomical Phenotypes: abnormal myocyte morphology , abnormal presomitic mesoderm morphology , abnormally localised myocyte , abnormally localised nucleus , decreased size of the myocyte , decreased size of the presomitic mesoderm
Source: fig.7.p
Article: XB-ART-45868, PubMed